QA: Royalty Pharma plc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001802768_2024_Royalty_Pharma_plc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'XOMA Royalty Corp', 'shared_tokens': {'royalty'}}]}

Graph

Absolute values for 0001802768, Royalty Pharma plc

  xvar xval
0 AssetsCurrent 1,274,193,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 15,107,658,000
4 LiabilitiesCurrent 161,377,000
5 LiabilitiesNoncurrent 6,136,185,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 250,579,136
9 ResearchAndDevelopmentExpense 36,569,582
10 remainder_Expenses 984,877,054
11 remainder_Revenues 2,364,058,771
12 remainder_NetIncome 143,105,808
13 remainder_ComprehensiveNetIncome -491,877,948
  yvar yval
0 Assets 16,381,851,000
1 Liabilities 6,297,562,000
2 Expenses 1,272,025,772
3 Revenues 2,364,058,771
4 StockholdersEquity 10,084,289,000
5 NetIncome 1,235,138,807
6 ComprehensiveNetIncome 989,199,833
7 BaseVar 13,475,240,650
8 EconomicCapitalRatiobeforeLimitedLiability 2.03
9 EconomicCapitalRatio 3.04

Edgar->Model Mapping

Feature Distribution

Change over Time